622 related articles for article (PubMed ID: 20003323)
1. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
2. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
Stolina M; Adamu S; Ominsky M; Dwyer D; Asuncion F; Geng Z; Middleton S; Brown H; Pretorius J; Schett G; Bolon B; Feige U; Zack D; Kostenuik PJ
J Bone Miner Res; 2005 Oct; 20(10):1756-65. PubMed ID: 16160733
[TBL] [Abstract][Full Text] [Related]
3. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Schett G; Middleton S; Bolon B; Stolina M; Brown H; Zhu L; Pretorius J; Zack DJ; Kostenuik P; Feige U
Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
[TBL] [Abstract][Full Text] [Related]
4. Anti-rheumatoid arthritis effects of iridoid glucosides from Lamiophlomis rotata (Benth.) kudo on adjuvant-induced arthritis in rats by OPG/RANKL/NF-κB signaling pathways.
Zhao X; Jiang S; Dong Q; Dang J; Liu Z; Han H; Tao Y; Yue H
J Ethnopharmacol; 2021 Feb; 266():113402. PubMed ID: 32980481
[TBL] [Abstract][Full Text] [Related]
5. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis.
Zhao H; Xu H; Qiao S; Lu C; Wang G; Liu M; Guo B; Tan Y; Ju D; Xiao C
Int Immunopharmacol; 2017 Oct; 51():114-123. PubMed ID: 28826044
[TBL] [Abstract][Full Text] [Related]
6. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of piperlongumine against adjuvant-induced arthritis in rats through modulating OPG/RANKL/NF-κB signaling pathway.
Wu SD; Wu XJ; Wang TT; Jiang F; Hu MW; Li R; Liu J; Cai L
J Pharm Pharmacol; 2024 Jun; 76(6):646-655. PubMed ID: 38334976
[TBL] [Abstract][Full Text] [Related]
8. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway.
Liu XY; Xu L; Wang Y; Li JX; Zhang Y; Zhang C; Wang SS; Zhang XM
Int Immunopharmacol; 2017 Mar; 44():105-114. PubMed ID: 28092862
[TBL] [Abstract][Full Text] [Related]
11. The peroxisome proliferator-activated receptor γ agonist pioglitazone preserves bone microarchitecture in experimental arthritis by reducing the interleukin-17-dependent osteoclastogenic pathway.
Koufany M; Chappard D; Netter P; Bastien C; Weryha G; Jouzeau JY; Moulin D
Arthritis Rheum; 2013 Dec; 65(12):3084-95. PubMed ID: 23982996
[TBL] [Abstract][Full Text] [Related]
12. Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression.
Wei ZF; Jiao XL; Wang T; Lu Q; Xia YF; Wang ZT; Guo QL; Chou GX; Dai Y
Acta Pharmacol Sin; 2013 Mar; 34(3):403-13. PubMed ID: 23396374
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
Schett G; Stolina M; Dwyer D; Zack D; Uderhardt S; Krönke G; Kostenuik P; Feige U
Arthritis Rheum; 2009 Sep; 60(9):2644-54. PubMed ID: 19714640
[TBL] [Abstract][Full Text] [Related]
14. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study.
Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K
Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710
[TBL] [Abstract][Full Text] [Related]
16. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
[TBL] [Abstract][Full Text] [Related]
17. The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.
Stolina M; Bolon B; Middleton S; Dwyer D; Brown H; Duryea D; Zhu L; Rohner A; Pretorius J; Kostenuik P; Feige U; Zack D
J Clin Immunol; 2009 Mar; 29(2):158-74. PubMed ID: 18726678
[TBL] [Abstract][Full Text] [Related]
18. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
[TBL] [Abstract][Full Text] [Related]
19. Modeling effects of dexamethasone on disease progression of bone mineral density in collagen-induced arthritic rats.
Lon HK; DuBois DC; Earp JC; Almon RR; Jusko WJ
Pharmacol Res Perspect; 2015 Oct; 3(5):e00169. PubMed ID: 26516581
[TBL] [Abstract][Full Text] [Related]
20. [Bushentongluo recipe (BSTL) attenuates bone destruction by inhibiting NF-κB/RANK/RANKL pathway in collagen-induced arthritis (CIA) rats].
Liu H; Wang G; Wang J; Wang T; Tian J; Wang L; Yang F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Mar; 37(3):205-211. PubMed ID: 33766227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
